HEDIS® Results
Medicaid HEDIS® Annual Rates. Molina’s scores for the past two years are below. You can see how Molina performs compared to the NCQA 66.67th percentile Quality Compass Benchmark.
|
Measure |
2024 Rate |
2025 Rate |
Goal |
|
Effectiveness of Care: Prevention and Screening |
|||
|
Adult Immunization Status (AIS-E) - Influenza (Total) |
- |
11.05 |
18.61 |
|
Adult Immunization Status (AIS-E) - Pneumococcal (66+) |
- |
13.05 |
58.40 |
|
Adult Immunization Status (AIS-E) - Td/Tdap (Total) |
- |
18.07 |
50.60 |
|
Breast Cancer Screening (BCS-E) |
- |
NA |
58.93 |
|
Cervical Cancer Screening (CCS) -Total |
- |
38.20 |
61.52 |
|
Childhood Immunization Status (CIS) - Combo 10 |
- |
25.38 |
30.41 |
|
Chlamydia Screening in Women (CHL) Total |
- |
37.80 |
62.81 |
|
Immunizations for Adolescents (IMA) - Combination 2 |
- |
31.42 |
40.39 |
|
Lead Screening in Children (LSC) -Total |
- |
53.78 |
74.62 |
|
Oral Evaluation, Dental Services (OED) - Total |
- |
37.83 |
49.54 |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - BMI percentile (Total) |
- |
48.18 |
87.69 |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Nutrition (Total) |
- |
38.20 |
77.70 |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Physical Activity (Total) |
- |
38.20 |
75.91 |
|
Effectiveness of Care: Respiratory |
|||
|
Asthma Medication Ratio (AMR) -Total |
- |
NA |
68.13 |
|
Appropriate Testing for Pharyngitis (CWP) -Total |
- |
83.34 |
87.31 |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) - Bronchodilator |
- |
75.84 |
86.25 |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) -Systemic Corticosteroid |
- |
66.29 |
74.92 |
|
Effectiveness of Care: Cardiovascular |
|||
|
Controlling High Blood Pressure (CBP) |
- |
17.27 |
70.35 |
|
Statin Therapy for Patients With Cardiovascular Disease (SPC) - Received Statin Therapy (Total) |
- |
NA |
82.94 |
|
Statin Therapy for Patients With Cardiovascular Disease (SPC) - Statin Adherence 80% (Total) |
- |
NA |
75.45 |
|
Effectiveness of Care: Diabetes |
|||
|
Blood Pressure Control for Patients With Diabetes (BPD) |
- |
10.26 |
74.21 |
|
Eye Exam for Patients With Diabetes (EED) |
- |
47.93 |
60.83 |
|
Glycemic Status Assessment for Patients With Diabetes (GSD) - Glycemic Status <8.0% |
- |
22.14 |
63.04 |
|
Glycemic Status Assessment for Patients With Diabetes (GSD) - Glycemic Status >9.0% |
- |
73.24 |
27.98 |
|
Kidney Health Evaluation for Patients With Diabetes (KED) - Total |
- |
39.69 |
46.17 |
|
Statin Therapy for Patients With Diabetes (SPD) - Received Statin Therapy |
- |
NA |
69.01 |
|
Statin Therapy for Patients With Diabetes (SPD) - Statin Adherence 80% |
- |
NA |
72.29 |
|
Effectiveness of Care: Behavioral Health |
|||
|
Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA) |
- |
59.83 |
69.67 |
|
Antidepressant Medication Management (AMM) - Effective Acute Phase Treatment |
- |
62.24 |
66.99 |
|
Antidepressant Medication Management (AMM) - Effective Continuation Phase Treatment |
- |
48.95 |
49.88 |
|
Diabetes Screening for People With Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
- |
81.23 |
84.36 |
|
Follow-Up After Emergency Department Visit for Mental Illness (FUM) - 30 days (Total) |
- |
55.12 |
62.41 |
|
Follow-Up After Emergency Department Visit for Mental Illness (FUM) - 7 days (Total) |
- |
34.63 |
46.71 |
|
Follow-Up After Emergency Department Visit for Substance Use (FUA) - 30 days (Total) |
- |
38.22 |
43.24 |
|
Follow-Up After Emergency Department Visit for Substance Use (FUA) - 7 days (Total) |
- |
23.85 |
30.53 |
|
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) - 30 days (Total) |
- |
45.51 |
62.24 |
|
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) - 7 days (Total) |
- |
27.31 |
40.55 |
|
Follow-Up After Hospitalization for Mental Illness (FUH) - 30 days (Total) |
- |
58.09 |
67.40 |
|
Follow-Up After Hospitalization for Mental Illness (FUH) - 7 days (Total) |
- |
37.99 |
45.08 |
|
Follow-Up Care for Children Prescribed ADHD Medication (ADD-E) - Initiation Phase |
- |
NA |
49.56 |
|
Follow-Up Care for Children Prescribed ADHD Medication (ADD-E) - Continuation and Maintenance Phase |
- |
NA |
58.69 |
|
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) - Blood Glucose and Cholesterol Testing (Total) |
- |
28.09 |
41.52 |
|
Effectiveness of Care: Access/Availability of Care |
|||
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) - Initiation of SUD Treatment - Total (Total) |
- |
38.83 |
49.03 |
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) - Engagement of SUD Treatment - Total (Total) |
- |
12.73 |
17.80 |
|
Prenatal and Postpartum Care (PPC) - Timeliness of Prenatal Care |
- |
85.64 |
88.56 |
|
Prenatal and Postpartum Care (PPC) - Postpartum Care |
- |
72.51 |
83.94 |
|
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) - Total |
- |
56.45 |
82.10 |
NA = Not Available Due to Small Denominator